SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech fireworks
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (2293)1/19/2006 1:30:53 PM
From: BulbaMan  Read Replies (1) of 7424
 
Rick: On the DVAX CC, I heard the same thing about the booster group as you did:
"the data was intermediate between placebo and the non-rechallenge group."
But, apparently, the JPM Securities analyst who downgraded DVAX this morning wasn't listening very well. In the AP story linked below he's quoted to say the booster group "not only lacked a significant improvement in symptoms, but actually fared worse than the placebo group."
Reminds me of the old line (slightly revised): Who do you trust, JMP or your lying ears ?
biz.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News